Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132647) titled 'Comparison of efficacy and safety of hepatotropic antiviral agents in chronic hepatitis B: A multicenter, two-arm, retrospective observational cohort study' on Sept. 16.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Chronic hepatitis B
Intervention:
Pradefovir (PDF) 45mg once daily:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-16
Target Sample Size: Pradefovir (PDF) 45mg once daily:100;TAF/TMF/ETV Combined Control Group:100;
Countries of Recruitment:
Ch...